Site updated at Wednesday, 22 June 2016

Living with Dementia

Beer compound could help fend off Alzheimer’s and Parkinson’s diseases

  • - Dementia News
  • Jan 28, 2015
  • Comments
  • Viewed: 0
Tags: | alzheimer's and parkinson's diseases | parkinson's diseases |

The health-promoting perks of wine have attracted the spotlight recently, leaving beer in the shadows. But scientists are discovering new ways in which the latter could be a more healthful beverage than once thought. They’re now reporting in ACS’ Journal of Agricultural and Food Chemistry that a compound from hops could protect brain cells from damage - and potentially slow the development of disorders such as Alzheimer’s and Parkinson’s diseases.

Jianguo Fang and colleagues note that mounting evidence suggests that oxidative damage to neuronal cells contributes to the development of diseases that originate in the brain. If scientists could find a way to guard these cells from this type of damage, they might be able to help prevent or slow down Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions. One compound found in hops, called xanthohumol, has gotten the attention of researchers for its potential benefits, including antioxidation, cardiovascular protection and anticancer properties.

Fang’s team decided to test xanthohumol’s effects on brain cells.

In lab tests, the researchers found that the compound could protect neuronal cells and potentially help slow the development of brain disorders. The scientists conclude xanthohumol could be a good candidate for fighting such conditions.


The authors acknowledge funding from Lanzhou University and the Natural Science Foundation of Gansu Province.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 161,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact .(JavaScript must be enabled to view this email address).


Michael Bernstein
.(JavaScript must be enabled to view this email address)


American Chemical Society

Journal - Journal of Agricultural and Food Chemistry

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]

Your details

* Required field

Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

Parkinson’s Disease Dementia

declines in memory1 - developing alzheimers2 - cvd1 - amyloid beta 42 peptide1 - epidemiology1 - amyloid-ß peptide1 - phosphodiester1 - wernicke’s encephalopathy1 - diet control1 - hypomanic1 - hearing1 - huntington gene1 - vascular risk factors2 - pdad1 - tia2 - sleep tied to alzheimer's1 - cause tuberculosis1 - bonfiglio1 - high-cholesterol diet1 - regular exercise1 - dementia care program1 - executive function1 - quantitative structural neuroimaging1 - alzheimer's researchers1 - dementia-related diseases1 - saykin1 - amyloid beta Αβ plaques1 - impassable plaques1 - familial alzheimer's disease2 - progressive neurodegenerative disorder1 -